IL6 and myocardial infarction: Recently, in assessing the effect of Anti-IL-6 treatment in a myocardial infarction (ASSAIL-MI) trial, IL-6 inhibition by tocilizumab was reported to increase myocardial salvage in patients with acute STEMI [165].